The Translational Genomics Research Institute (TGen) and the University of Pennsylvania (Penn) will receive $18 million to research pancreatic cancer, Stand Up to Cancer (SU2C) announced today...
Drug used in stroke patients may reduce risk of Alzheimer's disease; improve learning and memory
A drug used to improve blood flow to the brain also could help improve learning and memory and reduce the risk of Alzheimer's disease, according to a recent study by investigators at TGen, Arizona State University and the Arizona Alzheimer's Consortium.
TGen's Dr. Haiyong Han is inspired by patients’ stories in his quest to find a cure for the most deadly of all cancers.
At first, Dr. Haiyong Han's scientific journey was a series of intuitively logical steps, starting from his hometown of Shaoxing, one of China's most culturally and historically significant cities.
But in more recent years, his e
Doctor thrives in duel role as TGen cancer researcher and medical school faculty
In her duel role as a TGen investigator and a medical school instructor, it is not enough for Dr. Suwon "Sue" Kim to simply teach.
She wants her doctors-in-training to go beyond memorizing texts and jump into research riddles.
"I like solving puzzles," said Kim, who
Casting A Genome-Wide Net in Search of Melanoma Genes
TGen Investigator Dr. Kevin Brown and a team from Down Under want to get under your skin.
Dr. Brown and researchers at Australia’s Queensland Institute of Medical Research have identified a set of genes that could help predict the risk of melanoma, the deadliest of skin cancers.
“Despite yea
A Personal Journey Leads to A Career in Research
If he wasn’t a scientist, TGen’s Dr. Nhan Tran says he might be on Wall Street looking for the “next big thing” or in corporate law asking, “What are the facts?”
But in his role as Associate Investigator in TGen’s Brain Tumor Research Lab, Dr. Tran has the opportunity to ask — and hopefully answer—
The Ben and Catherine Ivy Foundation will fund the Ivy Genomics-Based Medicine Project. The Ivy G.B.M. Project is a collaboration among nine U.S. institutions working together to better understand how the genetic differences in individual brain tumors can potentially inform the prediction of what will be the most effective treatment option for each patient...
Researchers at the Translational Genomics Research Institute (TGen) have identified a new approach to treating endometrial cancer patients that not only stops the growth of tumors, but kills the cancer cells. In a potentially major breakthrough, TGen scientists and collaborators at Washington University School of Medicine in St. Louis discovered that introducing a particular inhibitor drug can...
A team of investigators led by scientists at the Translational Genomics Research Institute (TGen) have found a way to identify possible suspects at crime scenes using only a small amount of DNA, even if it is mixed with hundreds of other genetic fingerprints. Using genotyping microarrays, the scientists were able to identify an individual's DNA from within a mix of DNA samples...
Podcasts
NewsFeed
CAREERS @ TGEN
PRINT THIS PAGE
